Watchlist
Loading...
US Stock MarketDetailed Quotes

BBIO BridgeBio Pharma

Watchlist
32.520 -1.090-3.24% Close 12/08 16:00 ET
32.700+0.180+0.55% Post 16:24 ET
34.490High32.155Low1.26MVolume
Full Hours
  • 5D
  • 1D
  • 1W
  • 1M
  • 1Q
  • 1Y

About BridgeBio Pharma Company

BridgeBio Pharma, Inc. engages in identifying and advancing transformative medicines to treat patients who suffer from Mendelian diseases. Its pipeline of development programs includes product candidates ranging from early discovery to late-stage development. The company was founded by Charles Homcy, Frank McCormick, Philip Reilly, and Neil Kumar in 2015 and is headquartered in Palo Alto, CA.

Revenue Breakdown

Business Currency:USD
2022/12/31
Stock NameRevenueRatio
License and services revenue76.09M98.00%
Product sales1.55M2.00%

Comments

Read more
Paper Trade Start
Symbol
Direction
Buy
Sell
Types
LMT Order
Price
QTY
Amount
--
Claim up to $1 million virtual fund, join moomoo paper trading today! Claim Now >